Latest ACR News
-
Arthritis & Rheumatology reports that treatment trends in juvenile idiopathic arthritis (JIA) in the last two decades finds rising use of newer biologic and targ
Dr Irwin Lim _connectedcare
Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655
Dr. John Cush RheumNow
Dr. John Cush RheumNow
Jonathan Hausmann MD hausmannMD
CAPS is caused by mutations in NLRP3, a component of the inflammasome. It is thought that NLRP3 mutations lead to the uncontrolled production of the inflammatory cytokine IL-1b.
Jonathan Hausmann MD hausmannMD
Jonathan Hausmann MD hausmannMD
Jonathan Hausmann MD hausmannMD
Jonathan Hausmann MD hausmannMD
Jonathan Hausmann MD hausmannMD
Jonathan Hausmann MD hausmannMD
Dr. Antoni Chan synovialjoints
The highlight of the last day of #ACR19 is the Rheumatology Roundup Highlights #ACRBest by Drs. John Cush @RheumNow and Arthur Kavanaugh @ACRheum always worth attending with great take home messages #rheum https://t.co/eMdvc2byKG